These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Quantitative assessment of retrograde ejaculation using semen analysis, comparison with a standardized qualitative questionnaire, and investigating the impact of rhBMP-2. Tepper G; Rabbani R; Yousefzadeh M; Prince D Spine (Phila Pa 1976); 2013 May; 38(10):841-5. PubMed ID: 23403551 [TBL] [Abstract][Full Text] [Related]
7. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study. Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858 [TBL] [Abstract][Full Text] [Related]
8. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions. Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173 [TBL] [Abstract][Full Text] [Related]
10. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer. Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984 [TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review. Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193 [TBL] [Abstract][Full Text] [Related]
12. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2. Lee DD; Kim JY J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904 [TBL] [Abstract][Full Text] [Related]
13. Multilevel anterior cervical discectomy and fusion with and without rhBMP-2: a comparison of dysphagia rates and outcomes in 150 patients. Lu DC; Tumialán LM; Chou D J Neurosurg Spine; 2013 Jan; 18(1):43-9. PubMed ID: 23157278 [TBL] [Abstract][Full Text] [Related]
16. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up. Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679 [TBL] [Abstract][Full Text] [Related]
17. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166 [TBL] [Abstract][Full Text] [Related]
18. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients. Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R Spine (Phila Pa 1976); 2013 Jun; 38(13):1137-45. PubMed ID: 23354111 [TBL] [Abstract][Full Text] [Related]
19. Incidence and outcome of graft resorption in anterior lumbar interbody fusion: using femoral ring allografts and recombinant human bone morphogenetic protein-2. Kayanja M; Orr RD Spine (Phila Pa 1976); 2014 Mar; 39(5):374-80. PubMed ID: 24299714 [TBL] [Abstract][Full Text] [Related]
20. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]